1.
Subclinical Left Ventricular Dysfunction Prevention in Breast Cancer Patients after FAC Chemotherapy: A Carvedilol Trial. IJIHS [Internet]. 2024 Mar. 30 [cited 2026 Jul. 14];12(1):55-64. Available from: https://journal.fk.unpad.ac.id/index.php/ijihs/article/view/3570